Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
Details for Australian Patent Application No. 2001271729 (hide)
International Classifications
Event Publications
17 August 2006 Assignment before Grant
Lexigen Pharmaceuticals Corp. The application has been assigned to Merck Patent GmbH 2002
4 January 2007 Application Accepted
Published as AU-B-2001271729
3 May 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser